Protein that makes tumor cells in breast cancer resistant to treatments
December 15th, 2010 - 6:15 pm ICT by ANIWashington, Dec 15 (ANI): Scientists have found a protein that makes tumor cells in breast cancer resistant to treatments.
Researchers at the Andalusian Institute for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Granada found that cFLIP -an inhibitor of death ligand-induced apoptosis- is not only essential in breast tumor cells resistance to TRAIL treatments (a death ligand with a potent therapeutic potential against cancer), but this protein is also key to the survival of such cancer cells.
They found that a variation in the expression of this protein may lead to the normal development of breast epithelium.
The study analyzed the role of cFLIP in breast cancer cells’ resistance to TRAIL-induced apoptosis. Thus, researchers concluded that cFLIP is key in these cells’ resistance to TRAIL.
Such conclusion was drawn from the evidence that the inhibition of their expression through treatments with Doxorubicin (anthracycline, widely used in chemotherapy) or with SAHA (Histone deacetylases inhibitor), as well as the silencing of its expression through cFLIP siRNA oligos (small interfering RNA), resulted in the sensitisation of breast cancer cells to TRAIL-induced apoptosis.
The researchers have proved that cFLIP plays a survival role in tumorous and non-tumorous breast epithelial cells, since the inhibition of its expression induces apoptosis. (ANI)
- Mushroom compound boosts cancer drug - Oct 12, 2011
- Overabundance of protein promotes growth of breast cancer stem cells - Feb 16, 2011
- Novel peptide 'kills' cancer cells more effective than current therapies - Jan 23, 2011
- Gene that prevents stem cells from turning cancerous identified - Oct 15, 2010
- New hope for cancer cure - Jul 08, 2011
- Gene makes ovarian cancer resistant to chemotherapy - Mar 03, 2011
- How ovarian cancer resists chemotherapy - Mar 03, 2011
- Small molecules 'could block cell proliferation in cancerous human tumor' - Apr 14, 2011
- New discovery shows promise against non-small cell lung cancer - Dec 04, 2010
- How breast cancer cells dodge immune system and survive - Feb 02, 2011
- Red wine compound 'can give a boost to breast cancer treatment' - Feb 15, 2011
- Possible new treatment strategies for pancreatic cancer found - Mar 04, 2011
- Evidence of unusual drug-resistant breast tumours found - Oct 09, 2010
- New tool opens alternate door to prostate cancer diagnosis - Apr 03, 2011
- New discovery holds promise for liver cancer treatment - Mar 23, 2011
Tags: anthracycline, apoptosis, breast cancer, breast cancer cells, breast tumor, chemotherapy, doxorubicin, expression, histone, inhibition, ligand, molecular biology, protein, resistance, scientists, sirna, small interfering rna, tumor cells, university of granada, variation